Lombard Medical

What Lombard Medical does

Lombard Medical is a UK-based medical device company headquartered in Didcot, Oxfordshire, with a German subsidiary in Augsburg, specializing in minimally invasive endovascular stent graft systems for the treatment of abdominal and thoracic aortic aneurysms. The company's product portfolio spans three procedure categories: EVAR (Endovascular Aneurysm Repair) including Aorfix with proprietary halO Stent Technology for highly angulated anatomies (0-90°), Altura with bilateral D-stent design, and Minos ultra-low profile 14F/16F delivery; FEVAR (Fenestrated EVAR) led by Meridian, the only 14F fenestrated device on the market; and TEVAR (Thoracic EVAR) including Hercules (20,000+ global procedures), Castor branched unibody design, Hector triple-branched, Cratos, and Talos. Products are largely CE-marked with select FDA, CFDA, and Japan PMDA approvals, distributed via direct hospital sales with clinical specialist support and 3D case planning services to vascular surgeons, interventional radiologists, and specialized vascular centers primarily across EMEA and Japan.

The company generates revenue through hardware sales of aortic stent graft systems and accessories to hospitals and vascular surgery centers on a quote-based pricing model, with named-patient custom devices (Meridian, Castor) commanding bespoke manufacturing. Founded in 1994, Lombard originally developed Aorfix as its flagship product (CE 2001, FDA 2013, Japan 2014), later expanding through the 2017 acquisition of the Altura platform and the 2018 strategic partnership with MicroPort Endovastec, which culminated in MicroPort's full acquisition of Lombard in August 2024. The company now operates as a wholly-owned subsidiary of MicroPort Endovastec, with Kurt Lemvigh serving as CEO. Recent strategic emphasis has been on broadening the TEVAR portfolio (Cratos in April 2025, Hector in September 2025) and expanding European market presence through first-in-country procedures and distributor partnerships such as Endosynergy in Greece.

Name

Lombard Medical

Legal name

Lombard Medical Ltd

Website

https://lombardmedical.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

Lombard Medical is a UK-based medical device company developing and marketing minimally invasive aortic stent graft systems (EVAR, FEVAR, TEVAR) for treating abdominal and thoracic aortic aneurysms, serving vascular surgeons and hospitals across EMEA and Japan as a MicroPort Endovastec subsidiary.

Ownership category

akta.pro rank

Product category

Vascular Endoprostheses / Endovascular Aortic Aneurysm Repair Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)

Keywords

• Endovascular stent grafts
• Aortic aneurysm repair
• EVAR devices
• TEVAR implants
• Fenestrated aortic repair

Headquarters

HQ city

Didcot

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Medical Device Sales: Sale of aortic stent graft systems and accessories to hospitals and vascular surgery centers. Products are custom-made or standard devices ordered through sales representatives for specific patient procedures.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Lombard Medical develops, manufactures and markets a portfolio of minimally invasive endovascular stent graft systems used by vascular surgeons and interventional radiologists to treat abdominal and thoracic aortic aneurysms. The portfolio covers EVAR (Minos™, Aorfix™, Altura™), FEVAR (Meridian™) and TEVAR (Hercules™, Castor™, Cratos™, Hector™, Talos™) procedures, plus a Hercules™ Balloon Catheter accessory, sold to hospitals and vascular surgery centres through direct clinical sales.

Product overview

Lombard Medical is a UK-based medical device company focused solely on the minimally invasive treatment of aortic disease. The portfolio encompasses EVAR (Endovascular Aneurysm Repair), FEVAR (Fenestrated EVAR), and TEVAR (Thoracic Endovascular Aneurysm Repair) products. The EVAR portfolio includes Minos™ (ultra-low profile 14F), Aorfix™ (unique halO Stent Technology for complex anatomies with 0-90° angulation), and Altura™ (bilateral D-stent design eliminating contralateral cannulation). The FEVAR offering features Meridian™ (only available 14F fenestrated device). The TEVAR portfolio includes Hercules™ (low-profile with 20,000 procedures), Castor™ (branched unibody design preserving LSA), Cratos™, Hector™ (triple branched), and Talos™. An accessory line includes the Hercules Balloon Catheter. The company operates in partnership with MicroPort Endovastec, acquired in August 2024.

Differentiator

Problem solved

Functional benefit

Brands

• Aorfix: EVAR (Endovascular Aneurysm Repair) stent graft system with halO Stent Technology for treating abdominal aortic aneurysms with high neck angulations (0-90°).
• Altura
• Meridian
• Hercules
• Castor
• Talos
• Cratos
• Hector
• Minos
• Hercules Balloon Catheter

Products and services

• Minos™ - EVAR Ultra-low profile abdominal aortic stent graft for EVAR (Endovascular Aneurysm Repair), with 14F/16F main body, 12F iliac limbs, hydrophilic coating, tri-modular design and helical stent limbs for tortuous anatomies. Sold to hospitals and vascular surgery centres for the minimally invasive treatment of abdominal aortic aneurysms. CE-marked February 2020.
• Aorfix™ - EVAR Endovascular stent graft with proprietary halO Stent Technology™ that uniquely treats abdominal aortic aneurysms with neck angulations from 0° to 90° and tortuous iliac arteries; fish-mouth design supports sealing in changing neck morphologies. For vascular surgeons treating complex AAA anatomies. CE-marked 2001, FDA-approved 2013, Japan-approved 2014; MR Conditional.
• Altura™ - EVAR Endograft system with a unique bilateral D-stent design that eliminates contralateral limb cannulation, ultra-low profile 14F delivery system, braided nitinol stent and Quadrafix-Seal technology. Indicated for abdominal aortic aneurysm repair in patients with appropriate anatomy. CE-marked; MR Conditional.
• Meridian™ - FEVAR Fenestrated endograft system based on the Altura™ platform — the only commercially available 14F fenestrated device for FEVAR (Fenestrated Endovascular Aneurysm Repair). Non-standard, custom-built device supplied on a named-patient basis with double or single fenestration options, with or without SMA scallop. For complex AAA anatomies where fenestrated repair is indicated.
• Hercules™ - TEVAR Low-profile thoracic stent graft with dual sheath hydrophilic coating, PET soft inner sheath, varying stent heights for high conformability, multiple tapered configurations for dissection treatment and a novel proximal stent design. Indicated for TEVAR (Thoracic Endovascular Aneurysm Repair). CFDA-approved April 2015, CE-approved April 2020; MR Conditional. Over 20,000 global procedures performed.
• Castor™ - TEVAR Branched thoracic stent-graft with a unique unibody design to eliminate type III endoleaks and migrations while preserving the left subclavian artery (LSA). Custom-made to individual patient anatomy; proximal fixation in zones 2 and 3. Not CE-marked; supplied on a named-patient basis. MR Conditional.
• Cratos™ - TEVAR TEVAR (Thoracic Endovascular Aneurysm Repair) stent graft launched in Europe in April 2025, part of the expanded thoracic portfolio distributed by Lombard Medical from the MicroPort Endovastec range.
• Hector™ - TEVAR Triple branched thoracic stent-graft system combining an integrated branch (as in Castor™) with a pre-cannulated inner branch for complex arch repair. First implanted in Europe at Zurich University Hospital. Launched in September 2025.
• Talos™ - TEVAR TEVAR stent graft included in Lombard Medical's thoracic endovascular portfolio alongside Hercules™, Castor™, Cratos™ and Hector™ devices for the treatment of thoracic aortic aneurysms.
• Hercules™ Balloon Catheter Balloon inflation catheter accessory designed to assist expansion of vascular prostheses or temporary occlusion of large vessels, supporting stent graft apposition and improving conformability during endovascular procedures. CE-approved November 2016; not available for use in the USA.

Named customers6 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• MicroPort EndovastecflagshipStrategic or Co-development Partner · 1 January 2018Partnership established in 2018 with MicroPort Endovastec, a global leader in endovascular devices. Through this partnership, Lombard Medical offers MicroPort Endovastec products including Minos AAA stent graft, Hercules TAA stent graft, and Castor branched thoracic stent graft in addition to its own Aorfix and Altura products. In August 2024, MicroPort Endovastec acquired Lombard Medical, strengthening the strategic partnership.
• EndosynergycoreChannel Partner/ Reseller/ DistributorEndosynergy serves as the distributor for Meridian endograft in Greece, enabling local market access and distribution of Lombard Medical products in the Greek market.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Cook Medical: Long-standing competitor with the Zenith Flex EVAR and Zenith Alpha thoracic systems, plus fenestrated/branched offerings. Targets the same vascular surgeon customer base and overlapping aortic anatomies as Lombard.
• Medtronic: Global market leader in endovascular aortic repair with the Endurant EVAR system and Valiant/Talent TEVAR line. Directly competes with Lombard across abdominal and thoracic aneurysm procedures, with materially greater scale and US FDA-approved breadth.
• Artivion: Aortic device company offering the JOTEC and CryoLife stent graft lines, including branched and fenestrated products. Comparable niche specialist competing with Lombard's Meridian FEVAR and Castor branched TEVAR.
• Endologix: Specialist in EVAR with the AFX endograft system and the Alto portfolio. Closely comparable niche aortic device peer, focused on AAA repair like Lombard's Aorfix/Altura/Minos.
• Terumo Aortic: Provider of the Anaconda EVAR system and a broad thoracic/open surgical portfolio. Directly competes with Lombard in both EVAR and TEVAR and serves the same European vascular surgery centers.
• W. L. Gore & Associates: Manufactures the Excluder EVAR and TAG/CTAG TEVAR stent grafts, dominant in endovascular aortic repair. Competes head-to-head with Lombard's Aorfix, Altura, Hercules and Castor across standard and complex anatomies.

Others

• Penumbra: US-listed vascular intervention company referenced in Lombard's own competitive comparisons. While Penumbra's core focus is thrombectomy rather than aortic stent grafting, it is publicly cited alongside Lombard as a peer for benchmarking.

Broad incumbents

• Getinge: Broader medtech incumbent with a vascular surgery franchise including aortic grafts and hybrid OR solutions. Competes with Lombard indirectly via hospital contracts and capital equipment bundling.
• MicroPort Endovastec: Lombard's parent company and the original developer of the Minos, Hercules and Castor platforms. Operates as a broader Chinese endovascular incumbent with deeper APAC distribution than Lombard historically possessed.

Regional players

• Bentley (a B. Braun company): European-focused manufacturer of covered stents and vascular grafts, including offerings adjacent to Lombard's aortic portfolio. Comparable as a regional specialist competing for European tender business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lombard-medical-technologies

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lombard Medical